Many studies have demonstrated the promising potential of exogenously supplied GLP-1 in the treatment of type 2 diabetes as it can normalize glucose levels following subcutaneous injections in diabetic patients [5, 6]. Here, GLP1R is linked to type 2 diabetes mellitus.